In October, due to demand from existing healthcare partners, CTS began testing blood donors for antibody to Babesia microti under an Investigational New Drug exemption as a release test.
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...